BiotechTubeBiotechTube
Home/ClearB Therapeutics/Aileen Rubio
AR

Aileen Rubio

Chief Executive Officer (CEO)

ClearB Therapeutics

Therapeutic Areas

Infectious DiseaseHepatology

ClearB Therapeutics Pipeline

DrugIndicationPhase
CLB-4000Chronic Hepatitis B Infection (CHB)Phase 1b
CLB-4000 + Peg-IFNα-2aChronic Hepatitis B Infection (CHB)Phase 1b